Canonical 3′-deoxyribonucleotides as a chain terminator for HCV NS5B RNA-dependent RNA polymerase

Antiviral Research

Volumn 58, Issue 3, 2003, Pages 243-251

  Shim, Jaehoon ^a   Larson, Gabry ^a   Lai, Vicky ^a   Naim, Suhaila ^a   Wu, Jim Zhen ^a  

^a Ribapharm   (United States)

Author keywords

3 Deoxyribonucleotide; Hepatitis C virus; NS5B RdRp; Nucleoside chain terminator

Indexed keywords

DEOXYRIBONUCLEOTIDE; RNA POLYMERASE; CYTIDINE; NS 5 PROTEIN, HEPATITIS C VIRUS; NS-5 PROTEIN, HEPATITIS C VIRUS; RNA DIRECTED RNA POLYMERASE; VIRUS PROTEIN; VIRUS RNA;

ARTICLE; CATALYSIS; CELL ACTIVITY; CELL CULTURE; CHEMICAL BOND; ENZYME ANALYSIS; ENZYME INHIBITION; GENETIC ANALYSIS; HEPATITIS C VIRUS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; VIRUS REPLICATION; VIRUS STRAIN; BIOSYNTHESIS; CHEMISTRY; DNA TEMPLATE; DRUG EFFECT; GENETICS; HUMAN; METABOLISM; PHYSIOLOGY;

DNA VIRUSES; HEPATITIS C VIRUS;

CYTIDINE; DEOXYRIBONUCLEOTIDES; HEPACIVIRUS; HUMANS; RNA REPLICASE; RNA, VIRAL; STRUCTURE-ACTIVITY RELATIONSHIP; TEMPLATES, GENETIC; TUMOR CELLS, CULTURED; VIRAL NONSTRUCTURAL PROTEINS; VIRUS REPLICATION;

EID: 0037721329     PISSN: 01663542     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0166-3542(03)00007-X     Document Type: Article

References (24)

1. Alaoui-Lsmaili M.H., Hamel M., L'Heureux L., Nicolas O., Bilimoria D., Labonte P., Mounir S., Rando R.F. The hepatitis C virus NS5B RNA-dependent RNA polymerase activity and susceptibility to inhibitors is modulated by metal cations. J. Hum. Virol. 3(6):2000;306-316.
2. Axelrod V.D., Kramer F.R. Transcription from bacteriophage T7 and SP6 RNA polymerase promoters in the presence of 3′-deoxyribonucleoside 5′-triphosphate chain terminators. Biochemistry. 24(21):1985;5716-5723.
3. Boyer N., Marcellin P. Pathogenesis, diagnosis and management of hepatitis C. J. Hepatol. 32(Suppl. 1):2000;98-112.
4. Bressanelli S., Tomei L., Rey F.A., De Francesco R. Structural analysis of the hepatitis C virus RNA polymerase in complex with ribonucleotides. J. Virol. 76(7):2002;3482-3492.
5. Choo Q.L., Kuo G., Weiner A.J., Overby L.R., Bradley D.W., Haughton M. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 244:1989;359-362.
6. Crumpacker, C., 2001. Antiviral therapy. In: Knipe, D.M., Howley, P.M. (Eds.), Fields Virology, 4th ed., vol. 1. Lippincott Williams & Wilkins, Philadelphia, pp. 393-433.
7. Davis G.L. Current therapy for chronic hepatitis C. Gastroenterology. 118:2000;S104-S114.
8. Gitterman C.O., Burg R.W., Boxer G.E., Meltz D., Hitt J. Relation of structure to activity of purine 3′-deoxynulleosides in KB cell and chick embryo fibroblast cell cultures1. J. Med. Chem. 8(5):1965;664-667.
9. Gohara D.W., Crotty S., Arnold J.J., Yoder J.D., Andino R., Cameron C.E. Poliovirus RNA-dependent RNA polymerase (3Dpol): structural, biochemical, and biological analysis of conserved structural motifs A and B. J. Biol. Chem. 275(33):2000;25523-25532.
10. Ismaili, H.M.A., Cheng, Y.-X., Lavallee, J.-F., Siddiqui, A., Storer, R., 2002. Method for the Treatment or Prevention of Flavivirus Infections Using Nucleoside Analogues, US 2002/0019363.
11. Lin T.S., Yang J.H., Liu M.C., Shen Z.Y., Cheng Y.C., Prusoff W.H., Birnbaum G.I., Giziewicz J., Ghazzouli I., Brankovan V., Feng J.-S., Hsiung G.-D. Synthesis and anticancer activity of various 3′-deoxy pyrimidine nucleoside analogs, and crystal structure of 1-(3-deoxy-beta-D-threo-pentofuranosyl) cytosine. J. Med. Chem. 34(2):1991;693-701.
12. Lohmann V., Korner F., Herian U., Bartenschlager R. Biochemical properties of hepatitis C virus NS5B RNA-dependent RNA polymerase and identification of amino acid sequence motifs essential for enzymatic activity. J. Virol. 71(11):1997;8416-8428.
13. Lohmann V., Korner F., Koch J., Herian U., Theilmann L., Bartenschlager R. Replication of subgenomic hepatitis C virus RNAs in a hepatoma cell line. Science. 285:1999;110-113.
14. Lohmann V., Roos A., Korner F., Koch J.O., Bartenschlager R. Biochemical and structural analysis of the NS5B RNA-dependent RNA polymerase of the hepatitis C virus. J. Viral. Hepat. 7(3):2000;167-174.
15. Makeyev E.V., Bamford D.H. Primer-independent RNA sequencing with bacteriophage phi6 RNA polymerase and chain terminators. RNA. 7(5):2001;774-781.
16. Oh J.W., Ito T., Lai M.M. A recombinant hepatitis C virus RNA-dependent RNA polymerase capable of copying the full-length viral RNA. J. Virol. 73(9):1999;7694-7702.
17. Shigeura H.T., Boxer G.E. Incorporation of 3′-deoxyadenosine-5′-triphosphate into RNA by RNA polymerase from Micrococcus lysodeikticus. Biochem. Biophys. Res. Commun. 17(6):1964;758-763.
18. Shim J.H., Larson G., Wu J.Z., Hong Z. Selection of 3′-template bases and initiating nucleotides by hepatitis C virus NS5B RNA-dependent RNA polymerase. J. Virol. 76(14):2002;7030-7039.
19. Tabor S., Richardson C.C. A single residue in DNA polymerases of the Escherichia coli DNA polymerase I family is critical for distinguishing between deoxy- and dideoxyribonucleotides. Proc. Natl. Acad. Sci. U.S.A. 92(14):1995;6339-6343.
20. Traut T.W. Physiological concentrations of purines and pyrimidines. Mol. Cell Biochem. 140(1):1994;1-22.
21. Walton E., Holly F.W., Boxer G.E., Nutt R.F. 3′-Deoxynucleosides. IV. Pyrimidine 3′-deoxynucleosides. J. Org. Chem. 31(4):1965a;1163-1169.
22. Walton E., Holly F.W., Boxer G.E., Nutt R.F., Jenkins S.R. 3′-Deoxynucleosides. II. Purine 3′-deoxynucleosides II. Purine 3′-deoxynucleosides. J. Med. Chem. 8(5):1965b;659-663.
23. Zhong W., Ferrari E., Lesburg C.A., Maag D., Ghosh S.K., Cameron C.E., Lau J.Y., Hong Z. Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase. J. Virol. 74(19):2000a;9134-9143.
24. Zhong W., Uss A.S., Ferrari E., Lau J.Y., Hong Z. De novo initiation of RNA synthesis by hepatitis C virus nonstructural protein 5B polymerase. J. Virol. 74(4):2000b;2017-2022.